Medtronic plc
Medtronic plc (MDT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MDT · as of Jun 8, 2026
Key Statistics
Explore Medtronic plc Data
mdt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 51 · Buy rate: 58.8%
The MDT analyst consensus is Buy, based on ratings from 51 Wall Street analysts over the past 3 months. The average 12-month price target is $96.57, representing +18.24% upside from the current price of $81.67.
Competitors & Peers
mdt competitorsMDT
BMY
BSX
CVS
EW
GSKStock Performance
Full HistoryAbout Medtronic plc
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implan…
what is medtronic plc · mdt stock overview · medtronic plc company profile · who is medtronic plc ceo · mdt NYSE · medtronic plc headquarters · medtronic plc business segments
About Stock Overview & Key Data
Medtronic plc (MDT) is a Healthcare company in the Medical - Devices industry, listed on NYSE since May 2, 1973. As of the latest trading session, MDT stock price is $81.67, with a market capitalization of $104.9B. The stock has returned -6.61% over the past 12 months and -14.98% year-to-date.
According to 51 Wall Street analysts, the consensus rating for Medtronic plc stock is Buy, with an average 12-month price target of $96.57. In fiscal year 2026, Medtronic plc reported revenue of $36.4B and net income of $4.8B. For detailed data — including Medtronic plc revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Medtronic plc (MDT) stock price is $81.67. The stock is traded on NYSE under the ticker symbol MDT. The 52-week range is $73.31 – $106.33.